On the other hand, targeted depletion of the non-coding interval on human chromosome 9p21 in mice provided direct evidence that the risk interval has an important role in regulation of cardiac CDKN2A and CDKN2B expression, suggesting that the region modulates CAD progression by altering the dynamics of vascular cell proliferation [11]. This evidence concerns the gene CDKN2B and coronary artery disorder.